Préverenges, Switzerland

Nathalie Jongen




Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Preverenges, CH (2002)
  • Préverenges, CH (2013)

Company Filing History:


Years Active: 2002-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nathalie Jongen: Innovator in Inhalable Medicaments

Introduction

Nathalie Jongen is a prominent inventor based in Préverenges, Switzerland. She has made significant contributions to the field of inhalable medicaments, holding 2 patents that showcase her innovative approach to pharmaceutical manufacturing.

Latest Patents

Her latest patents include a process for the manufacture of powders of inhalable medicaments. This invention relates to an improved method for producing powders by crystallization from a supersaturated fluid containing the medicament. The method involves passing the fluid along a tubular reactor. Another notable patent is a process for the production of powders by precipitation from a liquid reaction mixture. This process also utilizes a tubular reactor, where a segmented reaction flow comprised of discrete volumes of the reaction mixture is separated by a separating fluid that is substantially immiscible with the reaction mixture.

Career Highlights

Throughout her career, Nathalie has worked with reputable companies such as Calcitech Ltd and Boehringer Ingelheim Pharma GmbH & Co. KG. Her experience in these organizations has allowed her to refine her skills and contribute to advancements in pharmaceutical technology.

Collaborations

Nathalie has collaborated with notable professionals in her field, including Paul Bowen and Jacques Lemaitre. These partnerships have further enriched her work and expanded her impact on the industry.

Conclusion

Nathalie Jongen is a trailblazer in the development of inhalable medicaments, with her innovative patents reflecting her expertise and dedication to improving healthcare solutions. Her contributions continue to influence the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…